UK markets closed

Boston Scientific Corporation (BSX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
73.17-0.09 (-0.12%)
At close: 04:00PM EDT
72.50 -0.67 (-0.92%)
After hours: 07:51PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 107.55B
Enterprise value 116.18B
Trailing P/E 61.49
Forward P/E 31.55
PEG ratio (5-yr expected) 1.82
Price/sales (ttm)7.33
Price/book (mrq)5.58
Enterprise value/revenue 7.90
Enterprise value/EBITDA 35.67

Trading information

Stock price history

Beta (5Y monthly) 0.79
52-week change 338.58%
S&P500 52-week change 322.36%
52-week high 374.39
52-week low 348.35
50-day moving average 367.77
200-day moving average 357.99

Share statistics

Avg vol (3-month) 36.56M
Avg vol (10-day) 38.12M
Shares outstanding 51.47B
Implied shares outstanding 61.47B
Float 81.46B
% held by insiders 10.19%
% held by institutions 194.46%
Shares short (15 Apr 2024) 413.16M
Short ratio (15 Apr 2024) 42.5
Short % of float (15 Apr 2024) 40.90%
Short % of shares outstanding (15 Apr 2024) 40.90%
Shares short (prior month 15 Mar 2024) 411.48M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 306 Nov 2003

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 12.06%
Operating margin (ttm)18.88%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)14.71B
Revenue per share (ttm)10.06
Quarterly revenue growth (yoy)13.80%
Gross profit (ttm)N/A
EBITDA 3.74B
Net income avi to common (ttm)1.76B
Diluted EPS (ttm)1.19
Quarterly earnings growth (yoy)57.60%

Balance sheet

Total cash (mrq)865M
Total cash per share (mrq)0.59
Total debt (mrq)9.57B
Total debt/equity (mrq)48.99%
Current ratio (mrq)N/A
Book value per share (mrq)13.15

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A